|
Market Closed -
Nasdaq
23:00:00 17/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 4.130 USD | +1.23% |
|
+4.03% | +156.52% |
| 08-17 | B. Riley Raises Price Target on MacroGenics to $11 From $9, Keeps Buy Rating | MT |
| 08-13 | MacroGenics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Company Valuation: MacroGenics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 983.2 | 412.5 | 596.7 | 204 | 101.8 | 263.1 | - | - |
| Change | - | -58.04% | 44.66% | -65.82% | -50.07% | 158.31% | - | - |
| Enterprise Value (EV) | 983.2 | 412.5 | 366.9 | 204 | 101.8 | 263.1 | 263.1 | 263.1 |
| Change | - | -58.04% | -11.05% | -44.41% | -50.07% | 158.31% | 0% | 0% |
| P/E | -4.76x | -3.44x | -64.1x | -3.04x | -1.36x | -2.65x | -2.52x | -2.02x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.1x | 0.7x | -0x | -0.1x | -0.1x | -0.48x | -0.1x |
| Capitalization / Revenue | 12.7x | 2.71x | 10.2x | 1.36x | 0.68x | 2.43x | 2.9x | 2.92x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.43x | 2.9x | 2.92x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -2.85x | -2.01x | -1.57x |
| EV / FCF | -0x | -0x | -0x | -0x | -0x | -3.13x | -1.89x | -2.01x |
| FCF Yield | -15.3% | -22% | -13.4% | -35.3% | -81.5% | -31.9% | -52.9% | -49.8% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3.37 | -1.95 | -0.15 | -1.07 | -1.18 | -1.558 | -1.64 | -2.049 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 77.45 | 151.9 | 58.75 | 150 | 149.5 | 108.2 | 90.61 | 90.12 |
| EBITDA | -191.5 | -109.6 | -158.6 | - | - | - | - | - |
| EBIT 1 | -202.8 | -121.4 | -168.2 | -110.6 | -72.84 | -92.47 | -130.9 | -167.6 |
| Net income 1 | -202.1 | -119.8 | -9.058 | -66.97 | -74.62 | -88.7 | -138.1 | -180.5 |
| Net Debt | - | - | -229.8 | - | - | - | - | - |
| Reference price 2 | 16.050 | 6.710 | 9.620 | 3.250 | 1.610 | 4.130 | 4.130 | 4.130 |
| Nbr of stocks (in thousands) | 61,258 | 61,475 | 62,029 | 62,763 | 63,259 | 63,700 | - | - |
| Announcement Date | 2/24/22 A | 3/15/23 A | 3/7/24 A | 3/20/25 A | 3/9/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.62x | - | - | - | 260M | |
| 20.48x | 7.21x | 14.48x | 1.45% | 69.69B | |
| 31.56x | 9.12x | 44.38x | 0.04% | 61.24B | |
| -74.83x | 14.47x | -69.78x | -.--% | 26.77B | |
| 30.22x | 6.42x | 16.68x | -.--% | 26.12B | |
| -14.57x | 5.25x | -6.6x | -.--% | 24.07B | |
| 27.63x | 5.23x | 17.38x | -.--% | 20.39B | |
| 45.45x | 16.69x | 33.86x | 0.33% | 15.72B | |
| 17.54x | 5.22x | 12.19x | -.--% | 14.07B | |
| 1001.87x | 34.99x | 604.33x | -.--% | 14.03B | |
| Average | 108.27x | 11.62x | 74.10x | 0.2% | 27.24B | |
| Weighted average by Cap. | 63.81x | 9.84x | 42.90x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MGNX Stock
- Valuation MacroGenics, Inc.
Select your edition
All financial news and data tailored to specific country editions
